Establishment of periodontitis treatment method by inhibition of RANK-Toll like receptor signal
Establishment of periodontitis treatment method by inhibition of RANK-Toll like receptor signal
批准号:
17390497
负责人:
UDAGAWA Nobuyuki
金额:
$9.98万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
MDP是负责肽聚糖免疫佐剂活性的最小基本结构单位,广泛分布于革兰氏阴性和阳性细菌的细胞壁中。研究表明,MDP对免疫活性细胞具有多种生物学效应。结果表明,亚甲基二磷酸果糖注射小鼠可引起内毒素超敏反应:肿瘤坏死因子-α的产生增加,攻击注射内毒素后可致致死性休克。我们还发现,MDP协同增强了内毒素诱导的人单核细胞中促炎细胞因子的产生。最近,有人提出核苷酸结合寡聚化结构域(NOD)2是Apaf1/NOD蛋白家族的成员,是MDP的胞内感受器。NOD2由一个N端的caspase招募结构域、一个位于中心的核苷酸结合域和C端的富含亮氨酸的重复序列组成,是一个信号转导接头。促炎细胞因子和内毒素可促进NOD2的表达。1α、25(OH)2D3、前列腺素E_2、内毒素和…在小鼠成骨细胞和造血细胞共培养中,更多的IL-1α刺激破骨细胞的形成。MDP单独作用不能诱导破骨细胞的形成,但能促进脂多糖、IL-1α或肿瘤坏死因子-α诱导的破骨细胞形成,但不能促进1α、25(OH)2D3或PGE_2诱导的破骨细胞形成。MDP不能促进RANKL或肿瘤坏死因子-α诱导的破骨细胞前体细胞的形成。亚甲基二磷酸对脂多糖或肿瘤坏死因子-α诱导的成骨细胞RANKL表达上调,但对1-α,25(OH)2D3无明显影响。成骨细胞在内毒素、IL-1α或肿瘤坏死因子-α刺激下表达NOD2mRNA,但不表达1-α、25(OH)2D3。TLR4和MYD88对成骨细胞NOD2mRNA表达的诱导依赖于TLR4和MYD88,而TLR4和MYD88对成骨细胞NOD2mRNA的诱导作用不明显。小干扰RNA耗尽细胞内NOD2可阻断MDP诱导的成骨细胞RANKL基因表达上调。脂多糖和RANKL可刺激破骨细胞存活,MDP不能增强这一作用。这些结果提示,亚甲基二磷酸通过RANKL的表达协同促进脂多糖、IL-1α和肿瘤坏死因子-α诱导的破骨细胞的形成,NOD2介导的信号参与了亚甲基二磷酸诱导的成骨细胞RANKL的表达。较少
英文摘要
MDP, the minimal essential structural unit responsible for the immunoadjuvant activity of peptidoglycans, is distributed ubiquitously in cell walls of both Gram-negative and-positive bacteria. MDP has been shown to exert diverse biological effects on immunocompetent cells. We have shown that injection of MDP into mice resulted in endotoxin hypersensitivity : enhanced production of TNF-α and lethal shock upon challenge injection of LPS. We also showed that MDP synergistically enhanced LPS-induced proinflammatory cytokine production in human monocytic cells. Recently, it was proposed that nucleotide-binding oligomerization domain (Nod) 2, a member of the Apaf1/Nod protein family, is an intracellular sensor of MDP. Nod2 consists of an N-terminal caspase-recruitment domain, a centrally located nucleotide-binding domain and C-terminal leucine-rich repeats, and acts as a signal-transducing adaptor. Nod2 expression is enhanced by proinflammatory cytokines and LPS. 1 α,25(OH)2D3, PGE2, LPS and … More IL-1 a stimulate osteoclast formation in mouse cocultures of osteoblasts and hemopoietic cells. MDP alone could not induce osteoclast formation in the coculture, but enhanced osteoclast formation induced by LPS, IL-1α or TNF-α but not 1 α,25(OH)2D3 or PGE2. MDP failed to enhance osteoclast formation from osteoclast progenitors induced by RANKL or TNF-α. MDP up-regulated RANKL expression in osteoblasts treated with LPS or TNF-α but not 1 α,25(OH)2D3. Osteoblasts expressed mRNA of Nod2 in response to LPS, IL-1α or TNF-α but not 1 α,25(OH)2D3. Induction of Nod2 mRNA expression by LPS but not by TNF-α in osteoblasts was dependent on TLR4 and MyD88. The depletion of intracellular Nod2 by small interfering RNA blocked MDP-induced up-regulation of RANKL mRNA in osteoblasts. LPS and RANKL stimulated the survival of osteoclasts, and this effect was not enhanced by MDP. These results suggest that MDP synergistically enhances osteoclast formation induced by LPS, IL-1α and TNF-a through RANKL expression in osteoblasts, and that Nod2-mediated signals are involved in the MDP-induced RANKL expression in osteoblasts. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
--
发表时间:
2006
期刊:
J Oral Biosciences 48・(3)
影响因子:
--
作者:
[Nakamichi Y et al., Tsukiyama K et al., Itoh S et al., Yamamoto Y et al., Udagawa N et al.]
通讯作者:
Udagawa N et al.
DOI:
10.1210/en.2005-0451
发表时间:
2005-12-01
期刊:
ENDOCRINOLOGY
影响因子:
4.8
作者:
[Take, I, Kobayashi, Y, Takahashi, N]
通讯作者:
Takahashi, N
DOI:
10.1074/jbc.m500926200
发表时间:
2005-06-24
期刊:
JOURNAL OF BIOLOGICAL CHEMISTRY
影响因子:
4.8
作者:
[Kobayashi, Y, Take, I, Takahashi, N]
通讯作者:
Takahashi, N
Osteoblasts provide a suitable microenvironment for the action of receptor activator of NF-kB ligand
成骨细胞为 NF-kB 配体受体激活剂的作用提供合适的微环境
DOI:
--
发表时间:
2006
期刊:
Endocrinology 147
影响因子:
--
作者:
[Yohei Yamamoto, et. al.]
通讯作者:
et. al.
Osteoblasts provide a suitable microenvironment for the action of receptor activator of NF-κB ligand
成骨细胞为 NF-κB 配体受体激活剂的作用提供合适的微环境
DOI:
--
发表时间:
2006
期刊:
Endocrinology (In Press)
影响因子:
--
作者:
[Ohno-Matsui K, Ichinose S, Nakahama K, Yoshida T, Kojima A, Mochizuki M, Morita I, Yamamoto Y.]
通讯作者:
Yamamoto Y.
共 16 条
Exploration of seeds for development of a new drug targeting Bone-Vascular-Spleen axis
-
批准号:25670793
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2013
-
负责人:UDAGAWA Nobuyuki
-
依托单位:
Analysis of bone remodeling mechanism between osteoblasts and osteoclasts for the alveolar bone regeneration
-
批准号:24390417
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.73万
-
财政年份:2012
-
负责人:UDAGAWA Nobuyuki
-
依托单位:
Basic research on development of new treatment of alveolar bone regeneration
-
批准号:21390498
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.73万
-
财政年份:2009
-
负责人:UDAGAWA Nobuyuki
-
依托单位:
Elucidation of the regulated mechanism of bone metabolism by osteoclastic transcytosis.
-
批准号:19390476
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.15万
-
财政年份:2007
-
负责人:UDAGAWA Nobuyuki
-
依托单位:
Signal transduction of RANK and Toll-like receptor in alveolar bone destruction
-
批准号:15390565
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.47万
-
财政年份:2003
-
负责人:UDAGAWA Nobuyuki
-
依托单位:
Analysis of signal transduction of osteoclast differentiation factor (RANKL) in alveolar bone destruction
-
批准号:13470394
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.28万
-
财政年份:2001
-
负责人:UDAGAWA Nobuyuki
-
依托单位:
The physiological role of osteoclast differentiation factor.
-
批准号:11470393
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$3.65万
-
财政年份:1999
-
负责人:UDAGAWA Nobuyuki
-
依托单位:
Mechanism of osteoclastogenesis inhibitory action by interleukin 18
-
批准号:09671905
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1997
-
负责人:UDAGAWA Nobuyuki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于肠道菌群探讨健脾化痰方通过调节LPS/NF-κB信号通路改善多囊卵巢综合征的机制研究
-
批准号:2026JJ80146
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:余曦明
-
依托单位:
基于4D Flow MRI 技术联合HA/cRGD-GD-LPs对比剂增强扫描诊断肝纤维化分期的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李刚静
-
依托单位:
基于肠道微生态的他莫昔芬-LPS-OTUD6A-HDAC3轴诱导乳腺癌内分泌治疗耐药的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:祝琦
-
依托单位:
肺炎克雷伯菌WaaLCPS连接酶相关的CPS-LPS合成通路及致病机制的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:何平
-
依托单位:
基于肠道菌群介导的LPS/TLR4/NF-κB信号通路探讨针灸对脑缺血再灌注损伤大鼠的抑炎作用机制
-
批准号:2025JJ90298
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:赖碧玉
-
依托单位:
半夏白术天麻汤通过抑制肠源性LPS/NF-κB通路减少NETs形成抗高血压血管内皮损伤的机制研究
-
批准号:KLY25H270034
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李波
-
依托单位:
基于“肠-肾轴”研究金花葵非药用部位经菌群-代谢物-TLR4/NF-κB调控LPS炎症小鼠的作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:廖光琴
-
依托单位:
噬菌体抑制LPS-TLR4-NF-κB信号通路纠
正菌群失衡在子痫前期发病中的机制研
究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:吕莉娟
-
依托单位:
热灭活L.hilgardii通过Betaine募集MDSCs缓解LPS诱导急性肝损伤的机制研究
-
批准号:QN25H020022
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李学慧
-
依托单位:
肠杆菌Klebsiella pneumoniae衍生的LPS通过肝脏HADHA-K353乙酰化修饰加剧MASLD合并T2DM疾病进程的机制研究
-
批准号:2025JJ60788
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:罗武
-
依托单位: